|Day Low/High||2.90 / 3.00|
|52 Wk Low/High||0.00 / 11.00|
OTC Markets Group EVP Jason Paltrowitz to Speak on Panel on "Reg A+ Offerings"
Company Plans to file 2016 Fourth Quarter and Year End Financial Results by March 30, 2017
Single-Center Retrospective Data Also Demonstrate Therapy Extends Progression-Free Survival by 9 Months
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.